Ignite Creation Date:
2024-05-06 @ 4:22 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04964934
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-04
First Post:
2021-06-30
Brief Title:
Phase III Study to Assess AZD9833 CDK46 Inhibitor in HRHER2-MBC With Detectable ESR1m Before Progression SERENA-6
Sponsor:
Organization:
AstraZeneca